If findings from the SCARLET trial are highly significant, The Ohio State University Media Relations Team (a unit of University Communications) will assist with generation of press articles that will facilitate further dissemination of results to the general public.
← all excerpts
SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failure.
1
—
—